AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35844438 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment and care
Number of subjects: 74
Study 34656029 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative immune modulating nutrition (IMN) - Stresson, Nutricia Ltd. for 10-15 days
Number of subjects: 108
Study 34656029 — intervention group
Group type: COMPARATOR
Intervention: Isocaloric, isonitrogenous control feed - Nutrison High Protein, Nutricia for 10-15 days
Number of subjects: 108
Study 34656029 — intervention group
Group type: COMPARATOR
Intervention: Both groups
Number of subjects: 108
Study 34445964 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary care networks (targeted physicians)
Number of subjects: 0
Study 34445964 — intervention group
Group type: COMPARATOR
Intervention: Reference group (non-targeted physicians)
Number of subjects: 0
Study 34445964 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners
Number of subjects: 0
Study 34445964 — intervention group
Group type: EXPERIMENTAL
Intervention: Younger patients
Number of subjects: 0
Study 34445964 — intervention group
Group type: EXPERIMENTAL
Intervention: Female patients
Number of subjects: 0
Study 32629117 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-gamma release assay (IGRA)
Number of subjects: 336
Study 35067621 — intervention group
Group type: EXPERIMENTAL
Intervention: Laminar airflow system (LAS)
Number of subjects: 246
Study 35067621 — intervention group
Group type: COMPARATOR
Intervention: Conventional airflow system (CAS)
Number of subjects: 246
Study 35067621 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LAS and CAS)
Number of subjects: 246
Study 33548773 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline development process
Number of subjects: 19
Study 33548773 — intervention group
Group type: COMPARATOR
Intervention: High-quality randomized controlled trials
Number of subjects: 19
Study 33548773 — intervention group
Group type: EXPERIMENTAL
Intervention: Qualitative research, real-world data, clinical experience, patient testimony
Number of subjects: 19
Study 32092927 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental infant formula (EF)
Number of subjects: 122
Study 32092927 — intervention group
Group type: COMPARATOR
Intervention: Standard infant formula (SF)
Number of subjects: 122
Study 32092927 — intervention group
Group type: COMPARATOR
Intervention: Breastfed (BF)
Number of subjects: 122
Study 34310541 — intervention group
Group type: EXPERIMENTAL
Intervention: Fire suppression simulation
Number of subjects: 15
Study 34310541 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 15
Study 34063454 — intervention group
Group type: COMPARATOR
Intervention: Plyometric training (P)
Number of subjects: 30
Study 34063454 — intervention group
Group type: COMPARATOR
Intervention: Plyometric integrated with balance training (BP)
Number of subjects: 30
Study 34063454 — intervention group
Group type: EXPERIMENTAL
Intervention: Control group (C)
Number of subjects: 30
Study 32362548 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 2 - Depth of insertion determined by distance from skin puncture to second intercostal space
Number of subjects: 120
Study 32362548 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 4 - Length of catheter determined by height-based formula
Number of subjects: 120
Study 32362548 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 3 - Depth of insertion determined by distance from skin puncture to third intercostal space
Number of subjects: 120
Study 32362548 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 - Length of catheter determined empirically by operator experience
Number of subjects: 120
Study 32362548 — intervention group
Group type: COMPARATOR
Intervention: Comparison of all groups
Number of subjects: 120
Study 32362548 — intervention group
Group type: COMPARATOR
Intervention: Correlation with demographic data
Number of subjects: 120
Study 34198387 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D image reconstruction based on improved U-net network
Number of subjects: 40
Study 34198387 — intervention group
Group type: COMPARATOR
Intervention: Conventional thin-slice CT images
Number of subjects: 40
Study 32239481 — intervention group
Group type: EXPERIMENTAL
Intervention: Code status discussions with patients
Number of subjects: 403
Study 32239481 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical patients
Number of subjects: 403
Study 32239481 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical patients
Number of subjects: 403
Study 32239481 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians determining DNR status without patient consultation
Number of subjects: 403
Study 32239481 — intervention group
Group type: EXPERIMENTAL
Intervention: Physicians who defined DNR status without consultation
Number of subjects: 403
Study 32239481 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients recalling code status discussions
Number of subjects: 403
Study 36194218 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefepime 2 g/enmetazobactam 0.5 g
Number of subjects: 1041
Study 36194218 — intervention group
Group type: COMPARATOR
Intervention: Piperacillin 4 g/tazobactam 0.5 g
Number of subjects: 1041
Study 35460163 — intervention group
Group type: EXPERIMENTAL
Intervention: App-based treatment for urinary incontinence
Number of subjects: 262
Study 35460163 — intervention group
Group type: COMPARATOR
Intervention: Care-as-usual
Number of subjects: 262
Study 32707225 — intervention group
Group type: EXPERIMENTAL
Intervention: aMAP risk score (cut-off value of 50)
Number of subjects: 17374
Study 32707225 — intervention group
Group type: EXPERIMENTAL
Intervention: aMAP risk score (cut-off value of 60)
Number of subjects: 17374
Study 32707225 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative incidences of HCC in low-risk group (cut-off <50)
Number of subjects: 17374
Study 32707225 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative incidences of HCC in medium-risk group (cut-off 50-60)
Number of subjects: 17374
Study 32707225 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative incidences of HCC in high-risk group (cut-off >60)
Number of subjects: 17374
Study 35861106 — intervention group
Group type: EXPERIMENTAL
Intervention: Vision-screening tool used by nurses and other non-eye care health practitioners (NECHP)
Number of subjects: 0
Study 35861106 — intervention group
Group type: COMPARATOR
Intervention: Vision-screening tool (Group 1)
Number of subjects: 0
Study 35861106 — intervention group
Group type: COMPARATOR
Intervention: Comprehensive orthoptic assessment (Group 2)
Number of subjects: 0
Study 34274500 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Intravenous Anesthesia (TIVA)
Number of subjects: 22755
Study 34274500 — intervention group
Group type: COMPARATOR
Intervention: Balanced anesthesia (volatile inhalational and intravenous agents)
Number of subjects: 22755
Study 35742717 — intervention group
Group type: EXPERIMENTAL
Intervention: EMDR psychotherapy
Number of subjects: 30
Study 35742717 — intervention group
Group type: EXPERIMENTAL
Intervention: Trauma-focused cognitive behavioral therapy
Number of subjects: 30
Study 35742717 — intervention group
Group type: COMPARATOR
Intervention: Both therapies
Number of subjects: 30
Study 32076899 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized multiresolution scanning (RAMUS) approach
Number of subjects: 0
Study 32076899 — intervention group
Group type: EXPERIMENTAL
Intervention: Hierarchical Bayesian model (HBM)
Number of subjects: 0
Study 32076899 — intervention group
Group type: EXPERIMENTAL
Intervention: Inverse gamma (IG) distribution as primary hyperprior
Number of subjects: 0
Study 32888384 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipose tissue derived‐stromal vascular fraction (AD‐SVF)
Number of subjects: 40
Study 32888384 — intervention group
Group type: EXPERIMENTAL
Intervention: Adipose tissue derived‐stromal vascular fraction plus platelet‐rich plasma (AD‐SVF plus PRP)
Number of subjects: 40
Study 33202068 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of PROMs in RCTs
Number of subjects: 54
Study 33202068 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregation of domain scores
Number of subjects: 54
Study 33202068 — intervention group
Group type: COMPARATOR
Intervention: Exclusion of domains
Number of subjects: 54
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of β-carotene
Number of subjects: 612
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of vitamin C
Number of subjects: 612
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of carbohydrates
Number of subjects: 612
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of total fat/oil
Number of subjects: 612
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of saturated fatty acid (SFA)
Number of subjects: 612
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of cholesterol
Number of subjects: 612
Study 33301496 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary intake of iron
Number of subjects: 612
Study 35356624 — intervention group
Group type: EXPERIMENTAL
Intervention: Uterine Artery Embolization (UAE)
Number of subjects: 100
Study 35356624 — intervention group
Group type: COMPARATOR
Intervention: Uterine Artery Ligation (UAL)
Number of subjects: 100
Study 35356624 — intervention group
Group type: EXPERIMENTAL
Intervention: Both UAL and UAE
Number of subjects: 100
Study 34302228 — intervention group
Group type: EXPERIMENTAL
Intervention: P+P intervention (patients and their intimate partners)
Number of subjects: 301
Study 34302228 — intervention group
Group type: COMPARATOR
Intervention: P-only intervention (patients only)
Number of subjects: 301
Study 33382828 — intervention group
Group type: EXPERIMENTAL
Intervention: Sickle Cell Trait (SCT)
Number of subjects: 431
Study 33382828 — intervention group
Group type: EXPERIMENTAL
Intervention: Homozygous α-thalassemia and hemizygous G6PD deficiency
Number of subjects: 431
Study 33382828 — intervention group
Group type: COMPARATOR
Intervention: HbA1c
Number of subjects: 431
Study 35963082 — intervention group
Group type: EXPERIMENTAL
Intervention: Xylocaine 10% pump spray
Number of subjects: 80
Study 35963082 — intervention group
Group type: COMPARATOR
Intervention: Normal saline 0.9%
Number of subjects: 80
Study 33774172 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiotherapy (group 1)
Number of subjects: 150
Study 33774172 — intervention group
Group type: EXPERIMENTAL
Intervention: Acromioplasty and physiotherapy (group 2)
Number of subjects: 150
Study 33774172 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotator cuff repair, acromioplasty, and physiotherapy (group 3)
Number of subjects: 150
Study 33774172 — intervention group
Group type: COMPARATOR
Intervention: Trial population (all groups combined)
Number of subjects: 150
Study 32841543 — intervention group
Group type: EXPERIMENTAL
Intervention: Involved-field irradiation (IFI)
Number of subjects: 228
Study 32841543 — intervention group
Group type: COMPARATOR
Intervention: Elective nodal irradiation (ENI)
Number of subjects: 228
Study 34582077 — intervention group
Group type: EXPERIMENTAL
Intervention: Vocational rehabilitation group intervention alongside individualised vocational rehabilitation (IVR) for 8 weeks
Number of subjects: 49
Study 34582077 — intervention group
Group type: COMPARATOR
Intervention: Individualised vocational rehabilitation (IVR) only for 8 weeks
Number of subjects: 49
Study 35005871 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel hyaluronic acid injectable gel with 0.3% lidocaine (test device)
Number of subjects: 158
Study 35005871 — intervention group
Group type: COMPARATOR
Intervention: Commercially available injectable hyaluronic acid gel with 0.3% lidocaine (comparator)
Number of subjects: 158
Study 32468413 — intervention group
Group type: EXPERIMENTAL
Intervention: Antiviral therapy
Number of subjects: 0
Study 32468413 — intervention group
Group type: EXPERIMENTAL
Intervention: Routine care practices
Number of subjects: 0
Study 33169863 — intervention group
Group type: EXPERIMENTAL
Intervention: Single bolus of vitamin D(3) (300,000 IU)
Number of subjects: 38
Study 33169863 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 33169863 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 1,000 IU vitamin D(3)
Number of subjects: 38
Study 32540319 — intervention group
Group type: EXPERIMENTAL
Intervention: Survey on dentists' beliefs and behaviors concerning antibiotic prophylaxis (AP)
Number of subjects: 3584
Study 33470637 — intervention group
Group type: EXPERIMENTAL
Intervention: Interleukin-1 receptor antagonism as adjunct therapy
Number of subjects: 0
Study 33470637 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 35920045 — intervention group
Group type: EXPERIMENTAL
Intervention: Goat milk yogurt (GMY)
Number of subjects: 12
Study 35920045 — intervention group
Group type: EXPERIMENTAL
Intervention: GMY & C (308.64g GMY & 18.88g C)
Number of subjects: 12
Study 35920045 — intervention group
Group type: COMPARATOR
Intervention: D-glucose (25g)
Number of subjects: 12
Study 35920045 — intervention group
Group type: COMPARATOR
Intervention: Corinthian raisins (37.76g)
Number of subjects: 12
Study 35920045 — intervention group
Group type: COMPARATOR
Intervention: Sultana raisins (37.48g)
Number of subjects: 12
Study 33549444 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic Hardship Score (EHS; range 0–14) based on three domains: change in employment status, financial hardship, and financial hardship for health expenditures.
Number of subjects: 3646
Study 34090451 — intervention group
Group type: EXPERIMENTAL
Intervention: Betaine group (BG, n=14, 2g/day)
Number of subjects: 29
Study 34090451 — intervention group
Group type: COMPARATOR
Intervention: Placebo group (PG, n=15)
Number of subjects: 29
Study 35508529 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotics plus dietary fiber
Number of subjects: 0
Study 35508529 — intervention group
Group type: COMPARATOR
Intervention: Probiotics alone
Number of subjects: 0
Study 35508529 — intervention group
Group type: COMPARATOR
Intervention: Dietary fiber only
Number of subjects: 0
Study 35508529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 32898839 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggregate-level screening for ACEs
Number of subjects: 367
Study 32898839 — intervention group
Group type: EXPERIMENTAL
Intervention: PEARLS scores (general health assessment)
Number of subjects: 367
Study 32898839 — intervention group
Group type: EXPERIMENTAL
Intervention: PEARLS scores (Global Executive Functioning assessment)
Number of subjects: 367
Study 32898839 — intervention group
Group type: EXPERIMENTAL
Intervention: PEARLS scores (stomachaches)
Number of subjects: 367
Study 32898839 — intervention group
Group type: EXPERIMENTAL
Intervention: PEARLS scores (asthma)
Number of subjects: 367
Study 36060517 — intervention group
Group type: EXPERIMENTAL
Intervention: TP (docetaxel 75 mg/m², cisplatin 75 mg/m²)
Number of subjects: 361
Study 36060517 — intervention group
Group type: COMPARATOR
Intervention: TPF (docetaxel 60 mg/m², cisplatin 60 mg/m², 5-fluorouracil 600 mg/m²)
Number of subjects: 361
Study 33832384 — intervention group
Group type: EXPERIMENTAL
Intervention: Wellness intervention (yoga, mindfulness, walking)
Number of subjects: 0
Study 33832384 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 33407804 — intervention group
Group type: EXPERIMENTAL
Intervention: REGAIN programme: an eight week, online, home‐based, supervised, group rehabilitation programme.
Number of subjects: 535
Study 33407804 — intervention group
Group type: COMPARATOR
Intervention: Best-practice usual care: A thirty‐minute, online, one‐to‐one consultation with a REGAIN practitioner.
Number of subjects: 535
Study 33878462 — intervention group
Group type: EXPERIMENTAL
Intervention: Diphenhydramine Compound (Diphenhydramine + Ammonium Chloride) plus standard of care
Number of subjects: 120
Study 33878462 — intervention group
Group type: COMPARATOR
Intervention: Diphenhydramine alone and standard of care
Number of subjects: 120
Study 34788694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lefamulin 150 mg IV q12h for 5-7 days
Number of subjects: 1289
Study 34788694 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg IV q24h for 7 days
Number of subjects: 1289
Study 34788694 — intervention group
Group type: EXPERIMENTAL
Intervention: Lefamulin 600 mg oral q12h for 5 days
Number of subjects: 1289
Study 34788694 — intervention group
Group type: COMPARATOR
Intervention: Moxifloxacin 400 mg oral q24h for 7 days
Number of subjects: 1289
Study 35233731 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled triple therapy (once daily)
Number of subjects: 1801
Study 35233731 — intervention group
Group type: COMPARATOR
Intervention: Inhaled dual therapy (twice daily)
Number of subjects: 1801
Study 33190741 — intervention group
Group type: EXPERIMENTAL
Intervention: COPD
Number of subjects: 33
Study 33190741 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 33
Study 35092871 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led multidisciplinary team approach
Number of subjects: 235
Study 33253953 — intervention group
Group type: EXPERIMENTAL
Intervention: Observation group (patients with vascular MCI)
Number of subjects: 28
Study 35921281 — intervention group
Group type: EXPERIMENTAL
Intervention: Video Meeting Signals (VMS) training
Number of subjects: 100
Study 35921281 — intervention group
Group type: COMPARATOR
Intervention: Emoji response buttons training
Number of subjects: 100
Study 32394658 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture treatment (at Baihui (GV 20), Guanyuan (CV 4), Qihai (CV 6), Fengchi (GB 20), Zusanli (ST 36), Sanyinjiao (SP 6)), once a day, 5 times as one course, with 2 days interval between each course, total of 4 courses.
Number of subjects: 80
Study 32394658 — intervention group
Group type: COMPARATOR
Intervention: Conventional chemoradiotherapy and symptomatic treatment (control group).
Number of subjects: 80
Study 34784804 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused shockwave therapy (f‐ESWT)
Number of subjects: 104
Study 34784804 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound guided corticosteroid injection
Number of subjects: 104
Study 34450050 — intervention group
Group type: EXPERIMENTAL
Intervention: Men (FFR value 0.83 ±0.09)
Number of subjects: 1554
Study 34450050 — intervention group
Group type: EXPERIMENTAL
Intervention: Proximal lesions (PLs) in men (FFR value 0.83 ±0.10)
Number of subjects: 1554
Study 34450050 — intervention group
Group type: EXPERIMENTAL
Intervention: Primary endpoint in proximal lesions (PLs)
Number of subjects: 1554
Study 34450050 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferred lesions
Number of subjects: 1554
Study 34450050 — intervention group
Group type: COMPARATOR
Intervention: Non-proximal lesions (non-PLs)
Number of subjects: 1554
Study 34450050 — intervention group
Group type: COMPARATOR
Intervention: Revascularized lesions
Number of subjects: 1554
Study 32466231 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (6 g)
Number of subjects: 17
Study 32466231 — intervention group
Group type: EXPERIMENTAL
Intervention: Taurine supplementation (3 g)
Number of subjects: 17
Study 32466231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 35838058 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing intervention
Number of subjects: 12
Study 34948677 — intervention group
Group type: EXPERIMENTAL
Intervention: Garden intervention (Year 1)
Number of subjects: 250
Study 34948677 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control (Year 2)
Number of subjects: 250
Study 34948677 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 250
Study 32439248 — intervention group
Group type: EXPERIMENTAL
Intervention: New nutritional index (NNI)
Number of subjects: 984
Study 33922683 — intervention group
Group type: EXPERIMENTAL
Intervention: Time-Restricted Eating (TRE) for 12 weeks (8 h eating window)
Number of subjects: 20
Study 32678041 — intervention group
Group type: EXPERIMENTAL
Intervention: Electroacupuncture
Number of subjects: 420
Study 32678041 — intervention group
Group type: COMPARATOR
Intervention: Solifenacin
Number of subjects: 420
Study 32678041 — intervention group
Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 420
Study 34874833 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 253
Study 34874833 — intervention group
Group type: COMPARATOR
Intervention: Placebo/nil
Number of subjects: 253
Study 34622691 — intervention group
Group type: EXPERIMENTAL
Intervention: External valvuloplasty of the saphenofemoral junction
Number of subjects: 0
Study 32030845 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided posterior quadratus lumborum block with 0.25% bupivacaine 0.5 mL/kg
Number of subjects: 40
Study 32030845 — intervention group
Group type: COMPARATOR
Intervention: Ultrasound-guided ilioinguinal/iliohypogastric nerve block with 0.25% bupivacaine 0.2 mL/kg
Number of subjects: 40
Study 32368936 — intervention group
Group type: EXPERIMENTAL
Intervention: RehaCom rehabilitation training for 5 weeks (two 60-min sessions per week)
Number of subjects: 60
Study 32368936 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention specified)
Number of subjects: 60
Study 34838980 — intervention group
Group type: EXPERIMENTAL
Intervention: Sarcojoint® 1 package twice a day
Number of subjects: 66
Study 34838980 — intervention group
Group type: COMPARATOR
Intervention: Vitamin B as placebo (control)
Number of subjects: 66
Study 33686762 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimand framework application in clinical trials
Number of subjects: 0
Study 33686762 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomized phase 3 trials
Number of subjects: 0
Study 33686762 — intervention group
Group type: EXPERIMENTAL
Intervention: Estimand framework
Number of subjects: 0
Study 35357103 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin addition to total nutrition admixture (TNA)
Number of subjects: 208
Study 35357103 — intervention group
Group type: COMPARATOR
Intervention: Noninsulin group
Number of subjects: 208
Study 32740754 — intervention group
Group type: EXPERIMENTAL
Intervention: Renal Denervation (RDN)
Number of subjects: 0
Study 32740754 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 34082090 — intervention group
Group type: EXPERIMENTAL
Intervention: Typbar TCV® co-administered with MR and YF vaccines (Group 1)
Number of subjects: 100
Study 34082090 — intervention group
Group type: COMPARATOR
Intervention: Inactivated polio vaccine (IPV) co-administered with MR and YF vaccines (Group 2)
Number of subjects: 100